The immunogenicity and reactogenicity of Td booster vaccination
in Korean preadolescents, aged with 11-12 years old |
Soo Young Lee1, Ga Young Kwak1, Hye Rin Mok1, Jong Hyun Kim1, Jae Kyun Hur1, Kyung Il Lee1, Park Joon Su2, Sang Hyuk Ma3, Hwang Min Kim4, Jin Han Kang1 |
1Department of Pediatrics, The Catholic University of Korea 2Department of Pediatrics, Soon Cheon Hyang University 3Department of Pediatrics, Changwon Fatima Hospital 4Department of Pediatrics, WonJu Yonsei University |
국내 11-12세 소아에서 Td 백신 추가접종의 면역원성과 안전성 평가 |
이수영1, 곽가영1, 목혜린1, 김종현1, 허재균1, 이경일1, 박준수2, 마상혁3, 김황민4, 강진한1 |
1가톨릭대학교 의과대학 소아과학교실 2순천향대학교 의과대학 소아과학교실 3창원파티마병원 소아청소년과 4연세대학교 원주의과대학 소아과학교실 |
Correspondence:
Jin Han Kang, Email: kjhan@catholic.ac.kr |
|
|
Abstract |
Purpose : This study was undertaken to evaluate the immunogenicity and reactogenicity of Td booster immunization in early preadolescents of Korea.
Methods : Healthy preadolescents, who had been vaccinated with 4 or 5 doses of DTaP vaccines until 6 years old age, were enrolled in this study from August 2006 to April 2007. Diphtheria and tetanus anti-toxoid antibodies in sera were measured by ELISA just before vaccination and 4 weeks after vaccination to evaluate immunogenicity. Local and systemic adverse reactions observed for 4 weeks after vaccination to access reactogenicity.
Results : 183 preadolescents were enrolled and mean age was 11.40±0.51 years old. All subjects achieved seroprotective diphtheria and tetanus anti-toxoid antibodies (titers ≥0.1 IU/mL) after Td booster vaccination. Among 183 vaccinees, 73.8% showed local adverse reactions and 37.2% systemic adverse reactions. Pain at injection site (66.1%) was the most common local reaction, and the most commonly shown systemic reaction was myalgia (17.5%). The adverse reactions were spontaneously relieved within three days after vaccination.
Conclusion : Td vaccine in this study was high immunogenic and showed an acceptable tolerance in Korean preadolescents. Td booster vaccination at 11-12 years old is the most effective method to increase compliance of the vaccination and to decrease the incidence of diphtheria and tetanus. |
Key Words:
Diphtheria-Tetanus vaccine, Immunization, Efficiency, Safety |
|